Inflammatory Bowel Disease Surgery in Melbourne

Inflammatory bowel disease (IBD) is a chronic condition characterised by persistent inflammation of the gastrointestinal tract. The two main forms are Crohn’s disease, which can affect any part of the digestive tract from mouth to anus, and ulcerative colitis, which is limited to the colon and rectum.

IBD affects approximately 100,000 Australians, with incidence continuing to rise, particularly among younger adults [1]. While medical therapy is the mainstay of treatment for most patients, surgery plays an important role in managing complications and disease refractory to medical treatment, and, in some cases, achieving long-term cure.

At Specialist Surgical Group, our Melbourne-based colorectal surgeon, Dr Thomas Tiang (MBBS, FRACS), has a special interest in inflammatory bowel disease and offers surgical assessment and treatment for patients with both Crohn’s disease and ulcerative colitis.

We consult from our Essendon and Bundoora clinics, with procedures performed at accredited hospitals in Melbourne. Inflammatory Bowel Disease surgery is part of our broader colorectal surgery service.

Call us today at (03) 9466 7338 to book a consultation.

Book Consultation

Mon – Fri: 9 AM – 5 PM

We are located in the heart of Essendon and Bundoora.

(03) 9466 7338

Is IBD surgery right for you?

IBD surgery may be appropriate if you:

  • Have ulcerative colitis that has not responded to optimised medical therapy, including immunosuppressants or biologic agents, and your gastroenterologist has referred you for a surgical opinion
  • Have been diagnosed with high-grade dysplasia or colorectal cancer arising in the setting of longstanding ulcerative colitis
  • Have experienced a severe acute flare of ulcerative colitis requiring hospitalisation that has not responded to intravenous corticosteroids or rescue biologic therapy
  • Have Crohn’s disease with a stricture causing partial or complete bowel obstruction that cannot be managed with endoscopic dilation or medical therapy alone
  • Have a fistula, abscess, or other perianal complication of Crohn’s disease requiring surgical drainage or staged surgical repair
  • Have had a segment of bowel perforated or developed toxic megacolon, requiring urgent or emergency surgical assessment
  • Are experiencing chronic symptoms from Crohn’s disease, including recurrent obstruction, malnutrition, or persistent fistulation, and your specialist team has recommended surgery as part of your ongoing management plan

Your suitability for surgery requires a thorough assessment, including review of your complete medical history, current and prior medications, recent imaging, colonoscopy findings, and your nutritional status.

Potential benefits

  • Curative potential in ulcerative colitis. Total proctocolectomy removes all disease-bearing tissue and eliminates the risk of disease recurrence and colorectal cancer arising from colitis. In patients undergoing restorative proctocolectomy with ileal pouch formation, the majority achieve satisfactory bowel function and significant improvements in quality of life without the need for a permanent stoma [2].
  • Relief from medically refractory symptoms. For patients whose symptoms persist despite optimal medical therapy, surgery provides durable relief from debilitating symptoms such as bloody diarrhoea, urgency, incontinence, and abdominal cramping. Studies consistently demonstrate improvements in health-related quality of life following surgery for chronic active IBD [3].
  • Avoidance of long-term corticosteroid dependence. Prolonged corticosteroid use carries significant risks, including bone loss, metabolic complications, and immunosuppression. Surgery allows many patients to reduce or eliminate their dependence on steroids and other immunosuppressive agents [1].
  • Effective management of complications. Surgical resection or strictureplasty addresses obstructive Crohn’s strictures, and surgical drainage and seton placement for perianal fistulae reduce septic complications and improve comfort in patients with complex perianal disease [4].
  • Cancer risk reduction in longstanding colitis. Patients with longstanding ulcerative colitis or Crohn’s colitis carry an elevated risk of colorectal cancer. Surgical resection removes the at-risk mucosa and provides definitive cancer prevention in appropriately selected patients, particularly those with confirmed dysplasia [5].
  • Minimally invasive surgery with favourable recovery. Laparoscopic colectomy and proctocolectomy are associated with reduced post-operative pain, shorter hospital stay, lower wound complication rates, and faster return to normal activity compared with open surgery, with equivalent clinical outcomes in experienced hands [6].

Potential risks

  • Anastomotic leak or pouch complications. The join between bowel ends, or between the ileal pouch and the anal canal in restorative proctocolectomy, can occasionally break down. Leak rates for ileal pouch formation are approximately 5-10% and may require further surgery or prolonged drainage. Pouchitis, inflammation of the ileal pouch, affects up to 50% of patients at some point and is usually managed with antibiotics [2].
  • Temporary or permanent stoma. Most patients undergoing restorative proctocolectomy will have a temporary loop ileostomy to protect the pouch while it heals, which is reversed at a planned second operation. Some patients are not suitable for ileal pouch formation and require a permanent end ileostomy. In emergency surgery for toxic megacolon or perforation, a temporary stoma is often necessary. We will discuss the likelihood of stoma formation in detail before your procedure.
  • Pouch failure. A proportion of ileal pouches fail over time due to complications such as persistent leak, pelvic sepsis, functional problems, or ongoing Crohn’s disease in a patient initially treated for presumed ulcerative colitis. The long-term pouch failure rate is approximately 5-10%, and affected patients may require conversion to a permanent ileostomy [2].
  • Bowel function changes. After ileal pouch formation, patients typically have 4-8 bowel movements per day, which represents a significant improvement over severe active colitis but is greater than normal bowel frequency. Most patients adapt well over time and are satisfied with their functional outcome. Dietary adjustment and, in some cases, anti-motility agents help manage bowel frequency [2].
  • Recurrence in Crohn’s disease. Unlike surgery for ulcerative colitis, surgery for Crohn’s disease is not curative. Post-operative recurrence in the bowel occurs in up to 50% of patients within 5 years of resection [4]. Post-operative medical therapy, typically with biologic agents or thiopurines, is used to reduce the risk of recurrence and will be coordinated with your gastroenterologist.
  • Urinary and sexual dysfunction. Surgery in the deep pelvis for proctocolectomy or rectal Crohn’s disease carries a risk of injury to the pelvic autonomic nerves, which can affect bladder function and sexual function in both men and women. Experienced surgical technique with nerve-sparing dissection reduces this risk but cannot entirely eliminate it.
  • Nutritional consequences. A significantly small bowel resection for Crohn’s disease may result in short bowel syndrome, reduced absorption of key nutrients, including vitamin B12, fat-soluble vitamins, and bile salts, and, in severe cases, dependence on parenteral nutrition. Intestinal-sparing techniques such as strictureplasty are used where possible to preserve bowel length [4].
  • General surgical risks. Bleeding, infection, respiratory complications, and anaesthesia-related risks apply to all major surgeries. Patients with IBD who are taking biologic agents or corticosteroids at the time of surgery carry a modestly elevated risk of infectious complications, and pre-operative medication optimisation is an important part of your surgical preparation [1].

Book a consultation today

(03) 9466 7338

Meet our team

Our colorectal surgeon is FRACS-qualified with specialist training at leading medical institutions in Australia. The procedures are performed at accredited Melbourne hospitals with full nursing and anaesthetic support.

Dr. Thomas Tiang, Colorectal and General Surgeon

Dr Thomas Tiang, MBBS, FRACS

Colorectal & General Surgeon

View profile

Your IBD surgery journey

The following steps provide a brief overview of your IBD surgery journey. Individual experiences will vary based on your specific health circumstances.

1. Initial consultation and health assessment

We will review your full IBD history, prior medical and surgical treatments, current medications, and relevant investigations, including colonoscopy reports and cross-sectional imaging.

For Crohn’s disease, an MRI of the perianal region may be arranged to characterise fistula anatomy. Your case will be discussed with your gastroenterologist prior to finalising a surgical recommendation.

2. Pre-operative preparation

Patients on biologic agents may require timing adjustments around surgery to reduce the risk of infection. Prolonged corticosteroid use increases surgical risk, and every effort is made to taper steroids before elective procedures where possible.

Nutritional optimisation is addressed if needed, pre-operative anaesthetic review is arranged, and stoma education is provided for patients in whom stoma formation is anticipated.

3. The IBD surgery procedure

The specific operation depends on your diagnosis and the nature of your disease. For ulcerative colitis, options include restorative proctocolectomy with ileal pouch formation (J-pouch), total colectomy with end ileostomy, or subtotal colectomy in the emergency setting.

For Crohn’s disease, surgery may involve segmental bowel resection, strictureplasty to widen narrowed segments while preserving bowel length, or perianal procedures including seton placement and fistula repair.

Most elective procedures are performed laparoscopically under general anaesthesia.

4. Hospital recovery

Hospital stay is typically 4-7 days for laparoscopic surgery, and longer following open or emergency procedures. Early mobilisation begins the day after surgery, oral fluids are introduced within 24 hours, and diet progresses as tolerated.

If a stoma has been formed, the stoma therapy nursing team provides education and ensures you are confident with stoma care before discharge.

5. Recovery at home

Most patients return to light daily activities within 2-4 weeks of laparoscopic surgery, with full recovery by 6-8 weeks.

Patients with a temporary ileostomy will have their stoma reversed at a planned operation approximately 8-12 weeks later, following confirmation that the pouch or bowel join has healed.

6. Long-term follow-up and ongoing IBD management

Ongoing collaboration with your gastroenterologist remains important after surgery, particularly for Crohn’s disease, where postoperative medical therapy reduces the risk of recurrence.

Colonoscopic surveillance of the pouch or remaining bowel is arranged at appropriate intervals. Surgical follow-up appointments are scheduled at 6 weeks and 3 months, with further review based on your individual circumstances.

Book a consultation today

(03) 9466 7338

IBD surgery FAQ

Can surgery cure inflammatory bowel disease?

The answer depends on which type of IBD you have. Total proctocolectomy for ulcerative colitis removes all diseased tissue from the colon and rectum and is considered a curative operation, as it eliminates the possibility of recurrence of colitis. However, patients with an ileal pouch may develop pouchitis, which requires ongoing management. Crohn’s disease is not curable with surgery because it can affect any part of the gastrointestinal tract. Surgery for Crohn’s disease is directed at managing complications such as strictures, fistulae, or refractory disease in a segment of bowel, with the aim of restoring quality of life and reducing the burden of active disease, rather than achieving cure.

When does my gastroenterologist refer me for surgery?

Referral for a surgical opinion is typically recommended when IBD is no longer responding adequately to medical therapy, when complications such as strictures, fistulae, abscesses, or perforations have developed, when dysplasia or cancer has been identified, or when the cumulative side effects of ongoing immunosuppression make a surgical approach preferable. In some cases, patients are referred urgently for emergency assessment when a severe acute flare fails to respond to intravenous treatment in the hospital. The decision to pursue surgery is made collaboratively between your gastroenterologist, you, and your colorectal surgeon.

What is an ileal pouch, and will I need a stoma?

An ileal pouch (also known as a J-pouch or ileal pouch-anal anastomosis, IPAA) is a reservoir fashioned from the end of the small bowel that replaces the rectum after proctocolectomy for ulcerative colitis. It allows most patients to avoid a permanent stoma and maintain bowel continuity through the anus. Most patients undergoing this procedure will have a temporary loop ileostomy for approximately 8-12 weeks while the pouch heals, followed by a planned reversal operation. Not all patients are suitable candidates for pouch formation; factors including sphincter function, overall health, nutritional status, and in some cases a final diagnosis of Crohn’s disease rather than ulcerative colitis may make a permanent end ileostomy a safer or more appropriate choice. We will discuss which option best suits your individual circumstances.

How long will I stay in the hospital?

Hospital stay depends on the type and complexity of the procedure. Most patients undergoing laparoscopic colectomy or proctocolectomy stay 4-7 days. Emergency surgery or open procedures typically require 7-10 days or longer. Enhanced recovery protocols, including early mobilisation, prompt resumption of diet, and multimodal pain management, are routinely used to support a smooth recovery and a shorter hospital stay wherever clinically appropriate.

What is pouchitis, and how is it managed?

Pouchitis is inflammation of the ileal pouch and is the most common long-term complication following restorative proctocolectomy, affecting up to 50% of patients at some point after their surgery. Symptoms include increased stool frequency, urgency, abdominal cramping, and occasionally bleeding. Acute pouchitis responds well to a short course of antibiotics, typically metronidazole or ciprofloxacin. Some patients develop chronic or recurrent pouchitis requiring longer-term antibiotic therapy, probiotics, or, in refractory cases, biologic treatment. Regular follow-up with your gastroenterologist is important for long-term monitoring of pouch function [2].

What happens if I have Crohn’s disease and need repeated bowel resections?

Repeated resections for Crohn’s disease carry a cumulative risk of short bowel syndrome, in which the remaining intestinal length is insufficient for adequate nutrient absorption. To minimise this risk, bowel-sparing surgical techniques including strictureplasty are used wherever possible, and post-operative medical therapy with biologic agents is recommended to reduce the risk and rate of disease recurrence. If you have had previous resections, we will carefully assess the remaining bowel length and factor this into the surgical planning for any further intervention [4].

Will I be able to stop my IBD medications after surgery?

This depends on your diagnosis and the type of surgery performed. Patients who have undergone total proctocolectomy for ulcerative colitis no longer require IBD-specific medical therapy for their colitis, though some patients with pouchitis will require ongoing treatment for the pouch. For Crohn’s disease, post-operative medical therapy is typically recommended to reduce the risk of disease recurrence at or near the surgical site, even when the patient feels well after surgery. Your gastroenterologist will guide the appropriate post-operative medication strategy for your individual situation.

How much does IBD surgery cost in Melbourne?

IBD surgery is covered under Medicare as a surgically indicated procedure. Patients with appropriate private hospital cover will have the majority of hospital accommodation and theatre costs covered by their health fund, subject to any applicable excess and waiting periods. Out-of-pocket expenses typically include surgeon, anaesthetist, and surgical assistant fees, and vary depending on procedure complexity and your level of health fund cover. A detailed fee estimate will be provided to you in writing before any procedure is scheduled. We recommend contacting your health fund to confirm your entitlements prior to your consultation.

Is laparoscopic surgery always possible for IBD?

Laparoscopic surgery is the preferred approach for eligible patients and is routinely performed for elective colectomy and proctocolectomy at our accredited Melbourne hospitals. However, prior abdominal surgery, extensive intra-abdominal adhesions, active perforation, or the technical complexity of certain procedures may require conversion to an open approach. Emergency surgery is also more likely to be performed open. We will discuss the planned approach and the possibility of conversion based on your individual circumstances.

Medical disclaimer

The information on this page is for general educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations, and does not create a doctor-patient relationship. Individual circumstances vary significantly, and nothing on this page should be used as a substitute for personalised advice from a qualified medical professional.

If you have concerns about your health, please seek medical attention promptly. To discuss your specific condition and treatment options with our team, please book a consultation by calling us at (03) 9466 7338.

References

[1] Leong RW, Armuzzi A. Inflammatory bowel disease. Lancet. 2024;403(10432):1261–1274. https://doi.org/10.1016/S0140-6736(23)02024-6

[2] Holubar SD, Lightner AL, Poylin V, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Dis Colon Rectum. 2021;64(11):1290–1314. https://doi.org/10.1097/DCR.0000000000002037

[3] Gu J, Stocchi L, Remzi F, Kiran RP. Factors associated with postoperative morbidity, conversion to open and the impact of laparoscopy on 30-day outcomes after restorative proctocolectomy. Colorectal Dis. 2013;15(2):181–189. https://doi.org/10.1111/j.1463-1318.2012.03148.x

[4] Torres J, Bonovas S, Doherty G, et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. J Crohns Colitis. 2020;14(1):4–22. https://doi.org/10.1093/ecco-jcc/jjz180

[5] Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17(3):802–808. https://doi.org/10.1002/ibd.21365

[6] Beyer-Berjot L, Maggiori L, Birnbaum D, et al. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg. 2013;258(2):275–282. https://doi.org/10.1097/SLA.0b013e31828e3e49